Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Department of Gastroenterology and Hepatology, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Eur J Epidemiol. 2023 Sep;38(9):973-984. doi: 10.1007/s10654-023-01028-x. Epub 2023 Jul 25.
Updated data on the incidence, prevalence, and regional differences of chronic liver disease are missing from many countries. In this study, we aimed to describe time trends, incidence, prevalence, and mortality of a wide range of chronic liver diseases in Sweden.
In this register-based, nationwide observational study, patients with a register-based diagnosis of chronic liver disease, during 2005-2019, were retrieved from the Swedish National Board of Health and Welfare. Annual age-standardized incidence and mortality rates, and prevalence per 100,000 inhabitants was calculated and stratified on age, sex, and geographical region.
The incidence of alcohol-related cirrhosis increased by 47% (2.6% annually), reaching an incidence rate of 13.1/100,000 inhabitants. The incidence rate of non-alcoholic fatty liver disease and unspecified liver cirrhosis increased by 217% and 87% (8.0 and 4.3% annually), respectively, reaching an incidence rate of 15.2 and 18.7/100,000 inhabitants, and a prevalence of 24.7 and 44.8/100,000 inhabitants. Furthermore, incidence rates of chronic hepatitis C declined steeply, but liver malignancies have become more common. The most common causes of liver-related mortality were alcohol-related liver disease and unspecified liver disease.
The incidence rates of diagnosed non-alcoholic fatty liver disease, alcohol-related cirrhosis, unspecified liver cirrhosis, and liver malignancies have increased during the last 15 years. Worryingly, mortality in several liver diseases increased, likely reflecting increasing incidences of cirrhosis in spite of a decreasing rate of hepatitis C. Significant disparities exist across sex and geographical regions, which need to be considered when allocating healthcare resources.
许多国家缺乏关于慢性肝病发病率、患病率和地域差异的最新数据。本研究旨在描述瑞典范围内多种慢性肝病的时间趋势、发病率、患病率和死亡率。
在这项基于登记的全国性观察性研究中,从瑞典国家公共卫生与福利局的登记册中检索到 2005-2019 年期间确诊为慢性肝病的患者。计算了每 10 万人中年龄标准化的发病率和死亡率以及患病率,并按年龄、性别和地理区域进行分层。
酒精性肝硬化的发病率增加了 47%(每年 2.6%),达到 13.1/10 万居民的发病率。非酒精性脂肪性肝病和未特指的肝硬化的发病率分别增加了 217%和 87%(每年分别为 8.0%和 4.3%),达到 15.2/10 万居民和 18.7/10 万居民的发病率,以及 24.7/10 万居民和 44.8/10 万居民的患病率。此外,慢性丙型肝炎的发病率急剧下降,但肝脏恶性肿瘤变得更为常见。与肝脏相关的死亡的最常见原因是酒精性肝病和未特指的肝脏疾病。
在过去 15 年中,诊断为非酒精性脂肪性肝病、酒精性肝硬化、未特指的肝硬化和肝脏恶性肿瘤的发病率有所增加。令人担忧的是,几种肝病的死亡率增加,这可能反映了尽管丙型肝炎的发病率下降,但肝硬化的发病率仍在上升。在性别和地理区域之间存在显著差异,在分配医疗资源时需要考虑这些差异。